PAINEX® DN roll-on
Natural health product licensed in Canada
- Licence holder
- BioCare Life Science
- NPN or DIN-HM
- 80007189
- Status
- Active licence
- Licence date
- 19 August 2008
- Revision date
- Not provided
- Form
- À bille
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dioxyde de silicium, Glycérine, Alcool éthylique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | 4 Tous les jours |
Uses authorised in Canada
Used to relieve cutaneous pain associated with conditions such as post-herpetic neuralgia and diabetic neuropathy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist. Avoid applying to injured or broken skin.
- Effets indésirables connus
Transient skin irritation, burning, stinging or redness are part of the normal, expected actions.
Source
Official Health Canada record, licence 80007189
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.